Mariangela Piazzani

Management of Dyslipidemia in Valle Camonica: A Clinical Journey Between Innovation and Tradition

Lorenzo Grassi, Mariangela Piazzani, Claudia Salice, Laura Tosetti et autres

Background: Elevated LDL-C is a major modifiable risk factor for atherosclerotic cardiovascular disease. Despite guideline recommendations, many high-risk coronary patients fail to achieve target LDL-C levels due to suboptimal therapy adherence and limited access to follow-up care. Telemedicine has emerged as a …

Anomalous origin of the coronary arteries: a brief summary for clinical practice

Lisa Serafini, Mariangela Piazzani, Alberto Madureri, Giuseppe Giacomarra et autres

Serafini, Lisa; Piazzani, Mariangela; Madureri, Alberto; Giacomarra, Giuseppe; Elia, Stefano; Chizzola, Giuliano; Metra, Marco; Adamo, Marianna Author Information

ca, it, us (code pays fourni par la source)

Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia

Francesco Fioretti, Mariangela Piazzani, Dario Cani, Alberto Madureri et autres

Abstract Background During the lockdown period in Italy, from March 11th to May 4th 2020, a progressive increase in COVID-19 cases occurred in all Italian regions, in particular in the Lombardy Region. The current rise in COVID-19 cases has led to an …

it (code pays fourni par la source)

IMPACT OF TELEMEDICINE NETWORK PROVIDED BY LOCAL PHARMACIES IN THE MANAGEMENT OF SYMPTOMATIC TACHYARRHYTMIAS DURING COVID-19 OUTBREAK

Savina Nodari, Francesco Fioretti, Mariangela Piazzani, Andrea Dell’Aquila et autres

it (code pays fourni par la source)

ROLE OF TELEMEDICINE NETWORK PROVIDED BY PHARMACIES TO DETECT ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN DURING CORONAVIRUS PANDEMIA

Savina Nodari, Francesco Fioretti, Mariangela Piazzani, Andrea Dell’Aquila et autres

it (code pays fourni par la source)

The possible role of genetic testing in the early identification of patients at increased risk of developing anthracycline-induced cardiotoxicity

Mariangela Piazzani, Francesco Fioretti, Matteo Gheza, Laura Lupi et autres

Abstract Background In the last years prognosis of cancer patients (pts) has been improved, but the develop of cardiotoxicity (CTX) in pts with low CV risk treated with cumulative doses of Anthracycline (ANT) considered safe, led to investigate the possible role of …

it (code pays fourni par la source)

P1453Safe multidisciplinary management of new therapies: the ritmo project (real time continuous web monitoring)

Laura Lupi, Fulvio Glisenti, C Castiello, Andrea Bonelli et autres

Abstract Background Fingolimod is an immunosuppressive drug that prevents the typical autoimmune responses of multiple sclerosis (MS). This drug can cause, even after the first dose, bradycardia and atrioventricular conduction block (AVB). According to a decree of the Committee for Medicinal Products …

it (code pays fourni par la source)

P1454A telemonitoring service approved by the ministry of health for a large-scale screening of silent and symptomatic atrial fibrillation

Laura Lupi, Fulvio Glisenti, Ilaria Papa, Mariangela Piazzani et autres

Abstract Introduction despite good progress in the management of patients with atrial fibrillation (AF), this disease remains one of the major cause of stroke, heart failure, sudden death and cardiovascular morbidity. Screening for silent AF is recommended in high risk population, especially …

it (code pays fourni par la source)

Cardiomyopathies.

Vincenza Precone, Geraldo Krasi, Giulia Guerri, Alberto Madureri et autres

The most common cardiomyopathies often present to primary care physicians with similar symptoms, despite the fact that they involve a variety of phenotypes and etiologies (1). Many have signs and symptoms common in heart failure, such as reduced ejection fraction, peripheral edema, …

it (code pays fourni par la source)

Abstract 11258: A Telemonitoring Service Approved by the Ministry of Health for a Large-Scale Screening of Silent and Symptomatic Atrial Fibrillation

Savina Nodari, Laura Lupi, Fulvio Glisenti, Gianfranco Gensini et autres

Introduction: despite good progress in the management of patients with atrial fibrillation (AF), this disease remains one of the major cause of stroke, heart failure, sudden death and cardiovascula...

Abstract 15720: A Telemonitoring Program for Primary and Secondary Prevention of Cardiovascular Disease

Savina Nodari, Laura Lupi, Fulvio Glisenti, Gianfranco Gensini et autres

Introduction: Cardiovascular diseases (CV) have a high prevalence and incidence and are associated with a high rate of mortality and hospitalization, resulting in high costs and poor quality of lif...

P4233Safe multidisciplinary management of new therapies: the RITMO project (Real Time Continuous Web Monitoring)

Laura Lupi, Fulvio Glisenti, Ilaria Papa, Mariangela Piazzani et autres

Background: Fingolimod is an immunosuppressive drug that prevents the typical autoimmune responses of multiple sclerosis (MS). This drug can cause, even after the first dose, bradycardia and atrioventricular conduction block (AVB). According to a decree of the Committee for Medicinal Products for …

it (code pays fourni par la source)